AAAAAA

   
Results: 1-9 |
Results: 9
POTENTIATION OF 2-CHLORODEOXYADENOSINE ACTIVITY BY BRYOSTATIN-1 IN THE RESISTANT CHRONIC LYMPHOCYTIC-LEUKEMIA CELL-LINE (WSU-CLL) - ASSOCIATION WITH INCREASED RATIOS OF DCK 5'-NT AND BAX/BCL-2/
Authors: MOHAMMAD RM BECK FWJ KATATO K HAMDY N WALL N ALKATIB A
Citation: Rm. Mohammad et al., POTENTIATION OF 2-CHLORODEOXYADENOSINE ACTIVITY BY BRYOSTATIN-1 IN THE RESISTANT CHRONIC LYMPHOCYTIC-LEUKEMIA CELL-LINE (WSU-CLL) - ASSOCIATION WITH INCREASED RATIOS OF DCK 5'-NT AND BAX/BCL-2/, Biological chemistry, 379(10), 1998, pp. 1253-1261
SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES
Authors: MOHAMMAD RM KATATO K ALMATCHY VP WALL N LIU KZ SCHULTZ CP MANTSCH HH VARTERASIAN M ALKATIB AM
Citation: Rm. Mohammad et al., SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES, Clinical cancer research, 4(2), 1998, pp. 445-453
SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES
Authors: MOHAMMAD RM KATATO K ALMATCHY VP WALL N LIU KZ SCHULTZ CP MANTSCH HH VARTERASIAN M ALKATIB AM
Citation: Rm. Mohammad et al., SEQUENTIAL TREATMENT OF HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA WITH BRYOSTATIN-1 FOLLOWED BY 2-CHLORODEOXYADENOSINE - PRECLINICAL STUDIES, Clinical cancer research, 4(2), 1998, pp. 445-453
ESTABLISHMENT OF A HUMAN B-CLL XENOGRAFT MODEL - UTILITY AS A PRECLINICAL THERAPEUTIC MODEL
Authors: MOHAMMAD RM MOHAMED AN HAMDAN MY VO T CHEN B KATATO K ABUBAKR YA DUGAN MC ALKATIB A
Citation: Rm. Mohammad et al., ESTABLISHMENT OF A HUMAN B-CLL XENOGRAFT MODEL - UTILITY AS A PRECLINICAL THERAPEUTIC MODEL, Leukemia, 10(1), 1996, pp. 130-137
SECONDARY ACUTE MYELOGENOUS LEUKEMIA FOLLOWING TREATMENT WITH ORAL ETOPOSIDE
Authors: KATATO K FLAHERTY L VARTERASIAN M
Citation: K. Katato et al., SECONDARY ACUTE MYELOGENOUS LEUKEMIA FOLLOWING TREATMENT WITH ORAL ETOPOSIDE, American journal of hematology, 53(1), 1996, pp. 54-55
ANTITUMOR-ACTIVITY OF BRYOSTATIN-1 AGAINST CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) IN A SCID MOUSE XENOGRAFT MODEL
Authors: ALKATIB A KATATO K VARTERASIAN M MOHAMED AN DUGAN M MOHAMMAD RM
Citation: A. Alkatib et al., ANTITUMOR-ACTIVITY OF BRYOSTATIN-1 AGAINST CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) IN A SCID MOUSE XENOGRAFT MODEL, Experimental hematology, 24(9), 1996, pp. 693-693
SEQUENTIAL TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) WITH BRYOSTATIN-I AND 2-CHLORODEOXYADENOSINE - A PRECLINICAL STUDY
Authors: KATATO K MOHAMMAD RM DUGAN MC SALEH M AHMAD I ALMATCHY VP VARTERASIAN ML ALKATIB A
Citation: K. Katato et al., SEQUENTIAL TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) WITH BRYOSTATIN-I AND 2-CHLORODEOXYADENOSINE - A PRECLINICAL STUDY, Blood, 88(10), 1996, pp. 2349-2349
CELL-CYCLE ARREST AND APOPTOSIS IN LYMPHOMA-CELLS INDUCED BY DOLASTATIN-10
Authors: ALKATIB A MAKI A ABUBAKR Y KATATO K PETTIT GR MOHAMMAD RM
Citation: A. Alkatib et al., CELL-CYCLE ARREST AND APOPTOSIS IN LYMPHOMA-CELLS INDUCED BY DOLASTATIN-10, Experimental hematology, 23(8), 1995, pp. 887-887
MATCHED SIBLING DONOR (MSD) AND MATCHED UNRELATED DONOR (MUD) RECIPIENTS OF ALLOGENIC BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOCYTIC-LEUKEMIA (CML)
Authors: KATATO K ABELLA E DU W ABUBAKR Y KARANES C
Citation: K. Katato et al., MATCHED SIBLING DONOR (MSD) AND MATCHED UNRELATED DONOR (MUD) RECIPIENTS OF ALLOGENIC BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOCYTIC-LEUKEMIA (CML), Blood, 86(10), 1995, pp. 3793-3793
Risultati: 1-9 |